Week In Review: Jiangsu Hansoh To Raise Up To $3 Billion In Hong Kong IPO

Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established.